Evaluation of a smoking cessation program for adults with severe mental illness in a public mental health service.
mental disorders
psychosis
smoking
smoking cessation
tobacco
Journal
Journal of psychiatric and mental health nursing
ISSN: 1365-2850
Titre abrégé: J Psychiatr Ment Health Nurs
Pays: England
ID NLM: 9439514
Informations de publication
Date de publication:
29 Mar 2024
29 Mar 2024
Historique:
revised:
27
02
2024
received:
03
10
2023
accepted:
13
03
2024
medline:
29
3
2024
pubmed:
29
3
2024
entrez:
29
3
2024
Statut:
aheadofprint
Résumé
Smoking rates have decreased in the general population but remain high among people with severe mental illness (SMI). An individualized smoking cessation program was tested with 99 adults with SMI. The program showed it is possible to help people with SMI smoke fewer cigarettes and reduce nicotine addiction. Customized smoking cessation programs are essential for those with high nicotine dependence and mental health challenges. Mental health services should offer tailored tobacco cessation programs because these programs can improve the health of people with mental illness who smoke. It is important for mental health services to follow government guidelines and provide evidence-based support. INTRODUCTION: Despite significant reductions in smoking rates in the general population over recent decades, smoking rates remain relatively unchanged among people with SMI. To evaluate the feasibility and preliminary effectiveness of the Keep Quitting in Mind pilot program, an individualized smoking cessation program for people experiencing SMI. In total, 99 adult participants with SMI and engaged with a community mental health service, participated in the intervention. The intervention included motivational interviewing and goal setting, in addition to provision of pharmaceutical aids (including nicotine replacement therapy). Analysis determined that the Keep Quitting in Mind pilot program was feasible in a public adult mental health service and participation in the program was associated with reductions in the number of cigarettes smoked daily and level of nicotine addiction. This real-world pilot program demonstrated feasibility and potential effectiveness in reducing smoking among adults with mental illness. Aligning with government guidelines, tailored smoking cessation programs are crucial due to high nicotine dependence and mental health complexities. Given the high rates of cigarette smoking by people with mental illness and the cardiometabolic health risks associated with this, mental health services should consider adding evidence-based and bespoke tobacco cessation programs as part of core business.
Types de publication
Journal Article
Langues
eng
Informations de copyright
© 2024 The Authors. Journal of Psychiatric and Mental Health Nursing published by John Wiley & Sons Ltd.
Références
Alvarez‐Jimenez, M., Gonzalez‐Blanch, C., Crespo‐Facorro, B., Hetrick, S., Rodriguez‐Sanchez, J. M., Perez‐Iglesias, R., & Luis, J. (2008). Antipsychotic‐induced weight gain in chronic and first‐episode psychotic disorders. CNS Drugs, 22(7), 547–562.
Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016). Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): A double‐blind, randomised, placebo‐controlled clinical trial. The Lancet, 387(10037), 2507–2520.
Aschbrenner, K. A., Brunette, M. F., McElvery, R., Naslund, J. A., Scherer, E. A., Pratt, S. I., & Bartels, S. J. (2015). Cigarette smoking and interest in quitting among overweight and obese adults with serious mental illness enrolled in a fitness intervention. The Journal of Nervous and Mental Disease, 203(6), 473–476. https://doi.org/10.1097/nmd.0000000000000309
Ashton, M., Rigby, A., & Galletly, C. (2013). What do 1000 smokers with mental illness say about their tobacco use? The Australian and New Zealand Journal of Psychiatry, 47(7), 631–636.
Baxter, A. J., Harris, M. G., Khatib, Y., Brugha, T. S., Bien, H., & Bhui, K. (2016). Reducing excess mortality due to chronic disease in people with severe mental illness: Meta‐review of health interventions. The British Journal of Psychiatry, 208(4), 322–329.
Boudreaux, E. D., Sullivan, A., Abar, B., Bernstein, S. L., Ginde, A. A., & Camargo, C. A. (2012). Motivation rulers for smoking cessation: A prospective observational examination of construct and predictive validity. Addiction Science & Clinical Practice, 7(1), 1–9.
Buchanan, T., White, S. L., Marshall, H., Carson‐Chahhoud, K. V., Magee, C. A., & Kelly, P. J. (2021). Time to rethink tobacco dependence treatment in Australia. Australian and New Zealand Journal of Public Health, 45(6), 538–540.
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013). Pharmacological interventions for smoking cessation: An overview and network meta‐analysis Cochrane database of Systematice reviews. In In. John Wiley & Sons.
Cooper, J., Mancuso, S. G., Borland, R., Slade, T., Galletly, C., & Castle, D. (2012). Tobacco smoking among people living with a psychotic illness: The second Australian survey of psychosis. The Australian and New Zealand Journal of Psychiatry, 46(9), 851–863.
Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., Pigato, G., Favaro, A., Monaco, F., Kohler, C., Vancampfort, D., Ward, P. B., Gaughran, F., Carvalho, A. F., & Stubbs, B. (2017). Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: A large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry, 16(2), 163–180.
Curtis, J., Watkins, A., Rosenbaum, S., Teasdale, S., Kalucy, M., Samaras, K., & Ward, P. B. (2016). Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic‐induced weight gain in first‐episode psychosis. Early Intervention in Psychiatry, 10(3), 267–276. https://doi.org/10.1111/eip.12230
Curtis, J., Zhang, C., McGuigan, B., Pavel‐Wood, E., Morell, R., Ward, P. B., Watkins, A., & Lappin, J. (2018). y‐QUIT: Smoking prevalence, engagement, and effectiveness of an individualized smoking cessation intervention in youth with severe mental illness. Frontiers in Psychiatry, 9, 683.
Dickerson, F., Schroeder, J., Katsafanas, E., Khushalani, S., Origoni, A. E., Savage, C., Schweinfurth, L., Stallings, C. R., Sweeney, K., & Yolken, R. H. (2018). Cigarette smoking by patients with serious mental illness, 1999–2016: An increasing disparity. Psychiatric Services, 69(2), 147–153.
Evins, A. E., Cather, C., Culhane, M. A., Birnbaum, A., Horowitz, J., Hsieh, E., Freudenreich, O., Henderson, D. C., Schoenfeld, D. A., Rigotti, N. A., & Goff, D. C. (2007). A 12‐week double‐blind, placebo‐controlled study of bupropion sr added to high‐dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Psychopharmacology, 27(4), 380–386.
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., Chatterton, M. L., Correll, C. U., Curtis, J., Gaughran, F., Heald, A., Hoare, E., Jackson, S. E., Kisely, S., Lovell, K., … Stubbs, B. (2019). The lancet psychiatry commission: A blueprint for protecting physical health in people with mental illness. The Lancet Psychiatry, 6(8), 675–712.
George, T. P., Vessicchio, J. C., Sacco, K. A., Weinberger, A. H., Dudas, M. M., Allen, T. M., Creeden, C. L., Potenza, M. N., Feingold, A., & Jatlow, P. I. (2008). A placebo‐controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biological Psychiatry, 63(11), 1092–1096.
Gilbody, S., Peckham, E., Bailey, D., Arundel, C., Heron, P., Crosland, S., Fairhurst, C., Hewitt, C., & Li, J. (2021). Smoking cessation in severe mental illness: Combined long‐term quit rates from the UK SCIMITAR trials programme. The British Journal of Psychiatry, 218(2), 95–97. https://doi.org/10.1192/bjp.2019.192
Gilbody, S., Peckham, E., Bailey, D., Arundel, C., Heron, P., Crosland, S., Fairhurst, C., Hewitt, C., Li, J., Parrott, S., Bradshaw, T., Horspool, M., Hughes, E., Hughes, T., Ker, S., Leahy, M., McCloud, T., Osborn, D., Reilly, J., … Vickers, C. (2019). Smoking cessation for people with severe mental illness (SCIMITAR+): A pragmatic randomised controlled trial. The Lancet Psychiatry, 6(5), 379–390. https://doi.org/10.1016/S2215‐0366(19)30047‐1
Gilbody, S., Peckham, E., Man, M.‐S., Mitchell, N., Li, J., Becque, T., Hewitt, C., Knowles, S., Bradshaw, T., Planner, C., Parrott, S., Michie, S., & Planner, C. (2015). Bespoke smoking cessation for people with severe mental ill health (SCIMITAR): A pilot randomised controlled trial. The Lancet Psychiatry, 2(5), 395–402.
Gronholm, P. C., Chowdhary, N., Barbui, C., Das‐Munshi, J., Kolappa, K., Thornicroft, G., Semrau, M., & Dua, T. (2021). Prevention and management of physical health conditions in adults with severe mental disorders: WHO recommendations. International Journal of Mental Health Systems, 15(1), 1–10.
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerström test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction, 86(9), 1119–1127.
IBM SPSS Statistics. (2021). IBM SPSS statistics for windows, version 28.0. IBM Corp. Google Search.
Lappin, J. M., Wijaya, M., Watkins, A., Morell, R., Teasdale, S., Lederman, O., Rosenbaum, S., Dick, S., Ward, P., & Curtis, J. (2018). Cardio‐metabolic risk and its management in a cohort of clozapine‐treated outpatients. Schizophrenia Research, 199, 367–373. https://doi.org/10.1016/j.schres.2018.02.035
Lowe, E. J., & Ackman, M. L. (2010). Impact of tobacco smoking cessation on stable clozapine or olanzapine treatment. Annals of Pharmacotherapy, 44(4), 727–732. https://doi.org/10.1345/aph.1M398
McClave, A. K., McKnight‐Eily, L. R., Davis, S. P., & Dube, S. R. (2010). Smoking characteristics of adults with selected lifetime mental illnesses: Results from the 2007 National Health Interview Survey. American Journal of Public Health, 100(12), 2464–2472.
McEwen, A., Hajek, P., McRobbie, H., & West, R. (2006). Manual of smoking cessation (guide for counsellors and practitioners). Blackwell Publishing.
Mitchell, A. J., Vancampfort, D., De Hert, M., & Stubbs, B. (2015). Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta‐analysis. General Hospital Psychiatry, 37(1), 14–23.
Morris, C. D., Waxmonsky, J. A., May, M. G., & Giese, A. A. (2009). What do persons with mental illnesses need to quit smoking? Mental health consumer and provider perspectives. Psychiatric Rehabilitation Journal, 32(4), 276–284. https://doi.org/10.2975/32.4.2009.276.284
National Mental Health Commission. (2016). Equally well consensus statement: Improving the physical health and wellbeing of people living with mental illness in Australia. NMHC.
NSW Ministry of Health. (2021). Physical health care for people living with mental health issues: A guideline. Australia.
Pinho, S., Rocha, V., & Vieira‐Coelho, M. A. (2021). Effectiveness of multimodal interventions focused on smoking cessation in patients with schizophrenia: A systematic review. Schizophrenia Research, 231, 145–153.
Plana‐Ripoll, O., Pedersen, C. B., Agerbo, E., Holtz, Y., Erlangsen, A., Canudas‐Romo, V., Andersen, P. K., Charlson, F. J., Christensen, M. K., Erskine, H. E., Ferrari, A. J., Iburg, K. M., Momen, N., Mortensen, P. B., Nordentoft, M., Santomauro, D. F., Scott, J. G., Whiteford, H. A., Weye, N., … Laursen, T. M. (2019). A comprehensive analysis of mortality‐related health metrics associated with mental disorders: A nationwide, register‐based cohort study. The Lancet, 394(10211), 1827–1835.
Prochaska, J. J., Das, S., & Young‐Wolff, K. C. (2017). Smoking, mental illness, and public health. Annual Review of Public Health, 38(1), 165–185. https://doi.org/10.1146/annurev‐publhealth‐031816‐044618
Productivity Commission. (2020). Mental health, report no. 95. Canberra.
Rüther, T., Bobes, J., De Hert, M., Svensson, T., Mann, K., Batra, A., Gorwood, P., Möller, H. J., & European Psychiatric Association. (2014). EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. European Psychiatry, 29(2), 65–82.
Schuch, F., Vancampfort, D., Firth, J., Rosenbaum, S., Ward, P., Reichert, T., Bagatini, N. C., Bgeginski, R., & Stubbs, B. (2017). Physical activity and sedentary behavior in people with major depressive disorder: A systematic review and meta‐analysis. Journal of Affective Disorders, 210, 139–150.
Siskind, D. J., Wu, B. T., Wong, T. T., Firth, J., & Kisely, S. (2020). Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: A systematic review, meta‐analysis, and network meta‐analysis. The Lancet Psychiatry, 7(9), 762–774.
Taylor, G. M., Itani, T., Thomas, K. H., Rai, D., Jones, T., Windmeijer, F., Martin, R. M., Munafò, M. R., Davies, N. M., & Taylor, A. E. (2020). Prescribing prevalence, effectiveness, and mental health safety of smoking cessation medicines in patients with mental disorders. Nicotine and Tobacco Research, 22(1), 48–57.
Teasdale, S. B., Ward, P. B., Samaras, K., Firth, J., Stubbs, B., Tripodi, E., & Burrows, T. L. (2019). Dietary intake of people with severe mental illness: Systematic review and meta‐analysis. The British Journal of Psychiatry, 214(5), 251–259. https://doi.org/10.1192/bjp.2019.20
The Royal Australian College of General Practitioners. (2019). Supporting smoking cessation: A guide for health professionals. Melbourne: The Royal Australian College of General Practitioners. RACGP.
Vancampfort, D., Firth, J., Schuch, F. B., Rosenbaum, S., Mugisha, J., Hallgren, M., Probst, M., Ward, P. B., Gaughran, F., De Hert, M., Carvalho, A. F., & Stubbs, B. (2017). Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: A global systematic review and meta‐analysis. World Psychiatry, 16(3), 308–315. https://doi.org/10.1002/wps.20458
White, S., McCaffrey, N., & Scollo, M. (2020). Tobacco dependence treatment in Australia–an untapped opportunity for reducing the smoking burden. Public Health Research & Practice, 30(3), e3032020.
Williams, J. M., Steinberg, M. L., Griffiths, K. G., & Cooperman, N. (2013). Smokers with behavioral health comorbidity should be designated a tobacco use disparity group. American Journal of Public Health, 103(9), 1549–1555.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.